Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455704 | SCV000538335 | uncertain significance | not specified | 2017-03-01 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 2 papers from HGMD. Fochier 2005 (16250003) detected variant in 1 individual with FH but no additional information. Huijgen 2010 (20506408) found that this variant doesn't segregate with hypercholesterolemia (LDL levels) in 6 families vs non-carriers. Low freq in ExAC. |
Labcorp Genetics |
RCV001837904 | SCV000659267 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002379405 | SCV002694760 | likely benign | Cardiovascular phenotype | 2023-09-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001837904 | SCV002814365 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2021-07-28 | criteria provided, single submitter | clinical testing |